IP Library Granted Patent US 9,580,472
Granted Patent B2
US 9,580,472 · App. 14/358,340 · Granted Feb 28, 2017

Anti-microbial peptides and methods of use thereof

Inventor: Guangshun Wang (Omaha, NE)
Assignee: Board of Regents of the University of Nebraska
C07K14/00A61K38/10A61K38/16A61K45/06C07K7/08C12Q1/18F03G7/10G06F19/22H02K51/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,580,472
App. No.
14/358,340
Granted
Feb 28, 2017
Kind
B2
Abstract

Anti-microbial peptides and methods of use are provided.

Claims (14)

1. An isolated anti-microbial peptide comprising the amino acid sequence GX 1 KRLVQRLKDX 2 LRNLV (SEQ ID NO: 58), wherein X 1 and X 2 are any amino acid.

2. The isolated anti-microbial peptide of claim 1 , consisting of SEQ ID NO: 58.

3. The isolated anti-microbial peptide of claim 1 , wherein the Leu at positions 5, 9, and 13 are D-amino acids.

4. The isolated anti-microbial peptide of claim 1 , wherein X 1 and X 2 are hydrophobic amino acids.

5. The isolated anti-microbial peptide of claim 1 , wherein X 1 and X 2 are biphenylalanine.

6. The isolated anti-microbial peptide of claim 1 , which is SEQ ID NO: 62.

7. The isolated anti-microbial peptide of claim 1 , wherein said peptide comprises at least one D-amino acid.

8. The isolated anti-microbial peptide of claim 1 , wherein said peptide comprises at least one modification selected from the group consisting of amidation and acetylation.

9. A composition comprising at least one anti-microbial peptide of claim 1 and at least one pharmaceutically acceptable carrier.

10. The composition of claim 9 , further comprising at least one antibiotic.

11. A method for inhibiting a microbial infection in a subject in need thereof, said method comprising administering to said subject the composition of claim 9 .

12. The method of claim 11 , further comprising the administration of at least one additional antibiotic.

13. The method of claim 11 , wherein said microbial infection is a staphylococcal infection.

14. The method of claim 13 , wherein said infection is a methicillin-resistant Staphylococcus aureus (MRSA) infection.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2015
From: WANG, GUANGSHUN; MISHRA, BISWAJIT
To: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 035784/0642 →
CONFIRMATORY LICENSE Recorded Jan 22, 2015
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034793/0371 →
CONFIRMATORY LICENSE Recorded Dec 16, 2014
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034642/0621 →
Continuity (2)
Provisional Application 61561990 · Nov 21, 2011
Related Publication 20140303069A1 · Oct 9, 2014